Morning Market Losers By: Benzinga via Benzinga November 13, 2014 at 09:49 AM EST Revance Therapeutics (NASDAQ: RVNC) shares dipped 28.33% to $15.05 after the company reported a Q3 net loss of $14.0 million, versus a ... Read More >> Related Stocks: J C Penney Company Inc Kohl's Corp LA Jolla Pharma Regulus Therapeutics Revance Therapeutics Sunpower Corp Texas Capital Bncsh